ERELAN

This brand name is authorized in Cyprus, Spain, Malta, Romania

Active ingredients

The drug ERELAN contains one active pharmaceutical ingredient (API):

1 Moxifloxacin UNII C53598599T - MOXIFLOXACIN HYDROCHLORIDE

Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair. Read about Moxifloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ERELAN Film-coated tablet		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01MA14	Moxifloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 83756
Country: MT	Medicines Authority	Identifier(s): MA032/12001
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65543001, W65543002, W65543003, W65543004, W65543005, W65543006, W65543007